Literature DB >> 6350031

Hematopoietic stem cell function in motheaten mice.

L D Shultz, C L Bailey, D R Coman.   

Abstract

Mice homozygous for the autosomal recessive mutation "motheaten" have normal numbers of multipotential hematopoietic stem cells in the bone marrow and spleen as determined by spleen colony assay. Histologic examination shows no qualitative abnormality in morphology of stem cell colonies in recipients of bone marrow or spleen cells from motheaten mice. Despite the apparently normal ontogeny, distribution, and differentiative capacity of CFU stem cells, bone marrow and spleen cells from motheaten mice fail to save congenic +/+ lethally gamma-irradiated hosts. This impaired lifesparing capacity is not due to defective self-renewal but appears to be due in part to pulmonary hemorrhage from alveolar capillaries in the gamma-irradiated hosts. Treatment of motheaten mice with 500 R gamma-irradiation followed by reconstitution with normal bone marrow cells increases the lifespan of this mutant to 10 months of age. The early onset of pneumonitis and subsequent short lifespan of motheaten mice is determined at the level of progenitor cells in the bone marrow.

Entities:  

Mesh:

Year:  1983        PMID: 6350031

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  12 in total

1.  Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5.

Authors:  Wenbin Xiao; Hong Hong; Yuko Kawakami; Clifford A Lowell; Toshiaki Kawakami
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

2.  A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development.

Authors:  C K Qu; Z Q Shi; R Shen; F Y Tsai; S H Orkin; G S Feng
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density.

Authors:  S Umeda; W G Beamer; K Takagi; M Naito; S Hayashi; H Yonemitsu; T Yi; L D Shultz
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

4.  "Viable motheaten," a new allele at the motheaten locus. I. Pathology.

Authors:  L D Shultz; D R Coman; C L Bailey; W G Beamer; C L Sidman
Journal:  Am J Pathol       Date:  1984-08       Impact factor: 4.307

5.  Role of tumor necrosis factor-alpha in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice.

Authors:  R S Thrall; S N Vogel; R Evans; L D Shultz
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

6.  Adoptive transfer of viable motheaten pathology in sublethally irradiated beige recipient mice.

Authors:  L Kuntz; E Montecino-Rodriguez; B Jachez; D Roman; F Loor
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

7.  Spontaneous insertion of a b2 element in the ptpn6 gene drives a systemic autoinflammatory disease in mice resembling neutrophilic dermatosis in humans.

Authors:  Andrew B Nesterovitch; Sandor Szanto; Andrea Gonda; Tamas Bardos; Katalin Kis-Toth; Vyacheslav A Adarichev; Katalin Olasz; Sheida Ghassemi-Najad; Mark D Hoffman; Michael D Tharp; Katalin Mikecz; Tibor T Glant
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

8.  Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1.

Authors:  H E Chen; S Chang; T Trub; B G Neel
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

9.  Increased expression of the stefin A cysteine proteinase inhibitor occurs in the myelomonocytic cell-infiltrated tissues of autoimmune motheaten mice.

Authors:  I Mlinaric-Rascan; S L Asa; K A Siminovitch
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

10.  Constitutive activation of SHP2 protein tyrosine phosphatase inhibits ICSBP-induced transcription of the gene encoding gp91PHOX during myeloid differentiation.

Authors:  Chunliu Zhu; Stephan Lindsey; Iwonna Konieczna; Elizabeth A Eklund
Journal:  J Leukoc Biol       Date:  2007-12-18       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.